Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Regulation of KIR3DL3 Expression via Mirna.

Nutalai R, Gaudieri S, Jumnainsong A, Leelayuwat C.

Genes (Basel). 2019 Aug 9;10(8). pii: E603. doi: 10.3390/genes10080603.

2.

IL-17 production by NKG2D-expressing CD56+ T cells in type 2 diabetes.

Phoksawat W, Jumnainsong A, Leelayuwat N, Leelayuwat C.

Mol Immunol. 2019 Feb;106:22-28. doi: 10.1016/j.molimm.2018.12.008. Epub 2018 Dec 18.

PMID:
30576948
3.

Immune Response to Opisthorchis viverrini Infection and Its Role in Pathology.

Sripa B, Jumnainsong A, Tangkawattana S, Haswell MR.

Adv Parasitol. 2018;102:73-95. doi: 10.1016/bs.apar.2018.08.003. Epub 2018 Sep 10. Review.

PMID:
30442311
4.

Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG.

Wangboon C, Worasith C, Thanan R, Eamudomkarn C, Techasen A, Sithithaworn J, Loilome W, Chamadol N, Pinlaor S, Jumnainsong A, Yongvanit P, Khuntikeo N, Bethony JM, Sithithaworn P.

Acta Trop. 2019 Jan;189:124-128. doi: 10.1016/j.actatropica.2018.10.003. Epub 2018 Oct 12.

PMID:
30321522
5.

Potent Neutralizing Human Monoclonal Antibodies Preferentially Target Mature Dengue Virus Particles: Implication for Novel Strategy for Dengue Vaccine.

Tsai WY, Chen HL, Tsai JJ, Dejnirattisai W, Jumnainsong A, Mongkolsapaya J, Screaton G, Crowe JE Jr, Wang WK.

J Virol. 2018 Nov 12;92(23). pii: e00556-18. doi: 10.1128/JVI.00556-18. Print 2018 Dec 1.

6.

5'-UTR and 3'-UTR Regulation of MICB Expression in Human Cancer Cells by Novel microRNAs.

Wongfieng W, Jumnainsong A, Chamgramol Y, Sripa B, Leelayuwat C.

Genes (Basel). 2017 Aug 29;8(9). pii: E213. doi: 10.3390/genes8090213.

7.

Aberrant NKG2D expression with IL-17 production of CD4+ T subsets in patients with type 2 diabetes.

Phoksawat W, Jumnainsong A, Leelayuwat N, Leelayuwat C.

Immunobiology. 2017 Oct;222(10):944-951. doi: 10.1016/j.imbio.2016.05.001. Epub 2016 May 3.

PMID:
27168217
8.

Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinsky A, Jumnainsong A, Edwards C, Quyen NT, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2015 Jul;16(7):785. doi: 10.1038/ni0715-785a. No abstract available.

PMID:
26086146
9.

Corrigendum: A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinsky A, Jumnainsong A, Edwards C, Quyen NT, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2015 May;16(5):544. doi: 10.1038/ni0515-544b. No abstract available.

PMID:
25898199
10.

Doxorubicin-conjugated bacteriophages carrying anti-MHC class I chain-related A for targeted cancer therapy in vitro.

Phumyen A, Jantasorn S, Jumnainsong A, Leelayuwat C.

Onco Targets Ther. 2014 Nov 28;7:2183-95. doi: 10.2147/OTT.S69315. eCollection 2014.

11.

A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus.

Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR.

Nat Immunol. 2015 Feb;16(2):170-177. doi: 10.1038/ni.3058. Epub 2014 Dec 15. Erratum in: Nat Immunol. 2015 May;16(5):544. Nat Immunol. 2015 Jul;16(7):785.

12.

High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection.

Tsai WY, Lai CY, Wu YC, Lin HE, Edwards C, Jumnainsong A, Kliks S, Halstead S, Mongkolsapaya J, Screaton GR, Wang WK.

J Virol. 2013 Dec;87(23):12562-75. doi: 10.1128/JVI.00871-13. Epub 2013 Sep 11.

13.

Allelic MHC class I chain related B (MICB) molecules affect the binding to the human cytomegalovirus (HCMV) unique long 16 (UL16) protein: implications for immune surveillance.

Klumkrathok K, Jumnainsong A, Leelayuwat C.

J Microbiol. 2013 Apr;51(2):241-6. doi: 10.1007/s12275-013-2514-1. Epub 2013 Apr 27.

PMID:
23625227
14.

Improved binding activity of antibodies against major histocompatibility complex class I chain-related gene A by phage display technology for cancer-targeted therapy.

Phumyen A, Jumnainsong A, Leelayuwat C.

J Biomed Biotechnol. 2012;2012:597647. doi: 10.1155/2012/597647. Epub 2012 Nov 21.

15.

Structural analysis of a dengue cross-reactive antibody complexed with envelope domain III reveals the molecular basis of cross-reactivity.

Midgley CM, Flanagan A, Tran HB, Dejnirattisai W, Chawansuntati K, Jumnainsong A, Wongwiwat W, Duangchinda T, Mongkolsapaya J, Grimes JM, Screaton GR.

J Immunol. 2012 May 15;188(10):4971-9. doi: 10.4049/jimmunol.1200227. Epub 2012 Apr 9.

16.

Lectin switching during dengue virus infection.

Dejnirattisai W, Webb AI, Chan V, Jumnainsong A, Davidson A, Mongkolsapaya J, Screaton G.

J Infect Dis. 2011 Jun 15;203(12):1775-83. doi: 10.1093/infdis/jir173.

17.

Cross-reacting antibodies enhance dengue virus infection in humans.

Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G.

Science. 2010 May 7;328(5979):745-8. doi: 10.1126/science.1185181. Erratum in: Science. 2010 Jul 9;329(5988):142.

Supplemental Content

Loading ...
Support Center